Dr Reddys Inks commercialisation Deal with Hatchtech
Dr Reddy’s Laboratories has announced the signing of a commercialisation deal with Hatchtech, an Australian pharmaceutical company for developing an […]
Tags: Australia, BSE Sensex, Business Partnership, Business/Finance, Canada, Clinical Research, Dr. Reddy's Laboratories, Drug safety, FDA Phase, food and drug administration, Hatchtech, Health/Medical/Pharmaceuticals, India, lice infestation, medicine, New Drug Application, new zealand, Pediculosis capitis, pharmaceutical, Pharmaceutical industry, Pharmaceutical sciences, Pharmacology, prescription head lice product, PROMIUS PHARMA LLC, russia, United States, US Food and Drug Administration, USD, Venezuela, Xeglyze Lotion
Theranos obtains FDA Approval for HSV-1 Test
Theranos, a leading health technology company, has obtained approval from the US Food and Drug Administration (FDA) for its test […]
Allergan to Buy Kythera Biopharmaceuticals for US$ 2.1 Billion
Allergan Plc, a botox-maker, said it has planned to buy Kythera Biopharmaceuticals Inc in a cash-and-stock deal valued at about […]
BioLight Life Sciences and Ora collaborates to enhance TeaRx Multi-parameter Diagnostic Test
BioLight Life Sciences Investments has entered into a collaboration agreement with Ora to enhance the clinical, regulatory and commercial development […]
Cobas KRAS Mutation Test by Roche Receives FDA Approval
Switzerland-based biotech company Roche has announced that it has received the U.S. Food and Drug Administration (FDA) approval for cobas […]
Jubilant Life Sciences receives ANDA approvals for Mycophenolate Mofetil and Rizatriptan
Jubilant Life Sciences Ltd, an integrated Pharmaceuticals and Life Sciences Company, has received Abbreviated New Drug Application (ANDA) final approval […]
Carestream to provide PACS for US Navy
According to a press release, Carestream is now the first company approved to provide the latest Picture Archiving and Communications […]
